RBRK
RUBRIK (RBRK) Insiders Sell About $1M in Stock as Shares Near $108
Two Rubrik insiders filed Form 4s on the same day, with CFO Kiran Kumar Choudary selling shares between $99.08 and $108.05.
RBRK
Two Rubrik insiders filed Form 4s on the same day, with CFO Kiran Kumar Choudary selling shares between $99.08 and $108.05.
RCAT
Founder and chairman Jeffrey Thompson sold 150,000 Red Cat shares at $7.74 and disposed of another 750,000 in a transaction coded as other.
CRWD
Board member Gerhard Watzinger sold about 120,000 CrowdStrike Class A shares on September 16 at prices between $236.30 and $241.45.
ADI
The chipmaker agreed to sell $3 billion of senior notes maturing between 2029 and 2036, with J.P. Morgan leading the underwriting syndicate.
UBER
Uber disposed of 29.4 million Aurora Innovation Class A shares at $6.2050 apiece, leaving it with 157.1 million shares.
AGPU
Axe Compute has closed the sale of its wholly owned subsidiary Helomics to Nasdaq-listed DataMeds AI, taking payment in restricted shares and a convertible note.
TPST
Tempest disclosed an exclusive collaboration, option and license agreement with Hebei Senlang Biotechnology covering rights to develop and commercialize licensed products.
LEU
Centrus will supply unobligated HALEU to microreactor developer Antares, with prepayments funding its Piketon enrichment expansion and deliveries before 2030.
UPXI
The Solana-focused treasury company booked $195.1 million in unrealized digital asset losses in fiscal 2026 while revenue rose to $25.0 million.
ABTS
Abits Group warns the share count from a discounted convertible note and a $250 million equity line will be substantially dilutive to existing holders.
RARE
The FDA approved Fayuvi (rebisufligene etisparvovec-hopf), the first treatment for pediatric patients with MPS IIIA, a rare inherited disorder.
RARE
Ultragenyx wins full FDA approval for FAYUVI, the first treatment ever cleared for MPS IIIA, and receives a Priority Review Voucher.